MedPath

广州白云山光华制药股份有限公司

Ownership
-
Established
1993-01-30
Employees
-
Market Cap
-
Website
www.gzghyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

297

NMPA:297

Drug Approvals

知柏地黄颗粒

Approval Number
国药准字Z20010014
Approval Date
Jun 12, 2024
NMPA

健肝灵胶囊

Approval Number
国药准字Z44020001
Approval Date
May 22, 2024
NMPA

莲芝消炎胶囊

Approval Number
国药准字Z44020010
Approval Date
Apr 15, 2024
NMPA

小柴胡颗粒

Approval Number
国药准字Z44020211
Approval Date
Apr 15, 2024
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H20045622
Approval Date
Apr 9, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H44020413
Approval Date
Apr 9, 2024
NMPA

Theophylline Sustained-release Tablets

Product Name
茶碱缓释片
Approval Number
国药准字H44020002
Approval Date
Apr 9, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H44020118
Approval Date
Apr 9, 2024
NMPA

Clindamycin Hydrochloride Capsules

Product Name
盐酸克林霉素胶囊
Approval Number
国药准字H20023686
Approval Date
Apr 9, 2024
NMPA

Gliclazide Tablets

Product Name
达尔得
Approval Number
国药准字H44020011
Approval Date
Apr 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.